Medicare Enrolled
Dr. Erdal Sarac, M.D.
Nephrology · Poland, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sarac from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarac?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sarac
Dr. Erdal Sarac is a nephrology specialist in Poland, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sarac performed 2,715 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sarac received a total of $14,959 from 47 pharmaceutical and/or device companies across 461 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sarac is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in OH
$14,959 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,715
Medicare services
Top 7% in OH for nephrology
Not available
Unique patients (not deduplicated)
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
877 | $47 | $100 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
393 | $61 | $97 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
256 | $91 | $143 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
247 | $64 | $97 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
222 | $36 | $75 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
150 | $92 | $140 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
119 | $267 | $430 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
98 | $55 | $138 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $133 | $271 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
83 | $224 | $350 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
45 | $224 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
39 | $130 | $192 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
32 | $2 | $15 |
| Ambulatory blood pressure monitoring, 1 day or longer This procedure involves wearing a device to record blood pressure over a day or longer. It includes analyzing the data, interpreting the results, and providing a report. |
22 | $31 | $250 |
| New patient office visit, complex (60-74 min) | 18 | $163 | $274 |
| Hemodialysis procedure requiring repeated evaluation A hemodialysis treatment that involves repeated evaluation during the procedure. |
14 | $78 | $402 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $100 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,959
Total received (2018-2024)
Avg $2,137/year across 7 years
Top 8% in OH for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
461
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,062
2023
$2,058
2022
$1,999
2021
$992
2020
$596
2019
$1,958
2018
$6,294
Payments by company (2024)
Amgen Inc.
$213
CALLIDITAS THERAPEUTICS US INC.
$156
AstraZeneca Pharmaceuticals LP
$111
Ardelyx, Inc.
$107
Novartis Pharmaceuticals Corporation
$96
Aurinia Pharma U.S., Inc.
$49
Otsuka America Pharmaceutical, Inc.
$47
ANI Pharmaceuticals, Inc.
$45
OPKO Pharmaceuticals, LLC
$39
Bayer Healthcare Pharmaceuticals Inc.
$36
bioMerieux Inc
$27
Daiichi Sankyo Inc.
$26
Travere Therapeutics, Inc.
$20
GlaxoSmithKline, LLC.
$20
Otsuka Pharmaceutical Development & Commercialization, Inc.
$19
Fresenius USA Marketing, Inc.
$18
Novo Nordisk Inc
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
OPKO Pharmaceuticals, LLC
$6,194
AstraZeneca Pharmaceuticals LP
$866
Horizon Therapeutics plc
$737
Relypsa, Inc.
$642
Amgen Inc.
$555
Otsuka America Pharmaceutical, Inc.
$465
Daiichi Sankyo Inc.
$433
NxStage Medical, Inc.
$409
Aurinia Pharma U.S., Inc.
$380
Vifor Pharma, Inc.
$355
CALLIDITAS THERAPEUTICS US INC.
$280
Mallinckrodt Hospital Products Inc.
$279
GlaxoSmithKline, LLC.
$256
Baxter Healthcare
$230
Bayer Healthcare Pharmaceuticals Inc.
$210
Novartis Pharmaceuticals Corporation
$180
Outset Medical Inc
$164
GENZYME CORPORATION
$163
BARD PERIPHERAL VASCULAR, INC.
$149
Mallinckrodt Enterprises LLC
$141
Alexion Pharmaceuticals, Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$128
Travere Therapeutics, Inc.
$125
Fresenius USA Marketing, Inc.
$112
Calliditas Therapeutics US Inc.
$107
Ardelyx, Inc.
$107
Renalytix AI, Inc.
$105
Ultragenyx Pharmaceutical Inc.
$99
Novo Nordisk Inc
$99
AKEBIA THERAPEUTICS INC
$95
Keryx Biopharmaceuticals, Inc.
$92
Gilead Sciences, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$83
Otsuka Pharmaceutical Development & Commercialization, Inc.
$73
Shire North American Group Inc
$54
Janssen Biotech, Inc.
$49
Janssen Pharmaceuticals, Inc
$49
ANI Pharmaceuticals, Inc.
$45
AMAG Pharmaceuticals, Inc.
$41
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Hikma Pharmaceuticals USA
$30
bioMerieux Inc
$27
Mallinckrodt LLC
$24
Alnylam Pharmaceuticals Inc.
$24
ARBOR PHARMACEUTICALS, INC.
$18
Genentech USA, Inc.
$18
Retrophin, Inc.
$11
Top 3 companies account for 52.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTHAR · AURYXIA · Auryxia · BENLYSTA · Crysvita · DISEASE STATE · ENTRESTO · Edarbi · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · GATTEX · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JYNARQUE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · Korsuva · LEQVIO · LIBERTY SELECT CYCLER · LOKELMA · LUPKYNIS · Mitigare · NXSTAGE SYSTEM ONE · Not Product Related · OXLUMO · Ozempic · PUREFLOW SL · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Renal - Non Product Related · Renal - PD · Rituxan · Rybelsus · SAMSCA · SIMPONI · SOLIRIS · SYSTEM ONE · System One · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · ULTOMIRIS · Ultomiris · VIDAS NEPHROCHECK · Veklury · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
17
County median income
$55,576
Nearest hospital to ZIP centroid (approximate)
HMHP ST ELIZABETH BOARDMAN HEALTH CENTER
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sarac is a clinical cardiology specialist, with above-average Medicare volume (top 7% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sarac experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Sarac performed 877 chronic care management, first 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sarac receive payments from pharmaceutical companies?
Yes. Dr. Sarac received a total of $14,959 from 47 companies across 461 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarac's costs compare to other nephrologists in Poland?
Dr. Sarac's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarac) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Poland
Browse nephrologists in Poland ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in OH
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in OH
Which OH nephrologists receive the most from drug and device companies.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology